|
|
WelcomeThe Department of Chemistry at Virginia Commonwealth University offers unique opportunities for interdisciplinary study at both the undergraduate and graduate level, as well as course offerings in the traditional areas of chemistry. We hope that this Web site will communicate our enthusiasm for chemistry, and you will be prompted to look more closely at our programs and offerings. Nick Farrell
![]() Research efforts in Hani El-Kaderi’s group are devoted to the design of low density and highly porous organic and inorganic polymers for use in storage, catalysis and sensing applications.
![]() Chemometric methods for the analysis of complex data sets are developed in Professor Sarah Rutan’s laboratory.
![]() Professor Scott Gronert’s laboratory is using mass spectrometry to study proteins and reaction mechanisms.
![]() Professor Matthew Hartman’s laboratory is developing large peptide libraries for use as drugs and biological tools.
![]() Computational research in Alenka Luzar’s group explores molecular and nanoscale hydration processes in natural and synthetic systems.
![]() The research team lead by Dr. Everett Carpenter is focused on synthesis of novel magnetic nanoparticles for electronic and biomedical applications.
![]() Professor Dusan Bratko develops analytical and simulation approaches to liquids, colloids and biopolymer solutions.
![]() Professor M. Samy El-Shall’s laboratory is studying the properties of clusters, nanoparticles and condensation nuclei for applications in nanocatalysis, gas phase polymerization, nucleation phenomena and atmospheric aerosols.
![]() Resonance Raman spectroscopy is used in Dr. James Terner’s laboratory to probe reaction mechanisms of biomedical interest.
![]() Free-label detection of bioprobes using streaming potentials in plastic microfluidic systems are being developed in Professor Julio Alvarez’s laboratory.
![]() Professor Nick Farrell’s research interests lie in the broad area of bioinorganic and medicinal inorganic chemistry with specific reference to platinum-based anticancer drugs. |
|
Virginia Commonwealth University |